Gaurav Aggarwal

Gaurav Aggarwal brings a rare combination of technical depth and marketing acumen to India’s healthcare and nuclear medicine sector. He completed his B.Tech in Electronics and Communication from Panjab University, Chandigarh, in 2011, followed by an MBA in Marketing from SP Jain School of Global Management (Singapore/Dubai) in 2014 — a dual foundation that has shaped his ability to bridge complex technical operations with commercial strategy.

Since joining the family business in 2014, Gaurav has spent the last 12 years driving its growth across multiple healthcare domains, including medical imaging equipment, diagnostic centers, and hospital operations. He currently serves as Director at Biomex Instruments Pvt. Ltd., Dynamic Diagnostics Pvt. Ltd., and leads Positroscint Pvt. Ltd. — a dedicated PET radiopharmaceutical manufacturer serving nuclear medicine facilities across North India.

Under his leadership, Positroscint was built to solve a firsthand operational challenge: unreliable third-party supply of Fluoro Deoxy Glucose (FDG), the most widely used PET radiotracer, which routinely disrupted time-sensitive patient care. Recognizing the growing burden of cancer diagnostics and the need for dependable radiotracer availability, Gaurav spearheaded the roughly five-year effort — delayed in part by the pandemic — to establish the company’s own manufacturing facility, reaching commercial production about two years ago.

His technical grounding in electronics and communication, combined with a marketing-focused MBA, has enabled him to lead with both engineering rigor and commercial vision — advancing regulatory compliance, manufacturing infrastructure, and logistics to strengthen India’s molecular imaging ecosystem. He continues to pursue new frontiers for the business, with an eye toward untouched opportunities in precision diagnostics and radiopharmaceutical innovation.